These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 35941981)

  • 21. Eyelid hygiene products: A scoping review.
    Bitton E; Ngo W; Dupont P
    Cont Lens Anterior Eye; 2019 Dec; 42(6):591-597. PubMed ID: 31635938
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical treatment of ocular demodecosis by lid scrub with tea tree oil.
    Gao YY; Di Pascuale MA; Elizondo A; Tseng SC
    Cornea; 2007 Feb; 26(2):136-43. PubMed ID: 17251800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Corneal Effects of Tea Tree Oil.
    Tharmarajah B; Coroneo MT
    Cornea; 2021 Oct; 40(10):1363-1364. PubMed ID: 34074891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of lid hygiene on the tear film and ocular surface, and the prevalence of Demodex blepharitis in university students.
    Murphy O; O' Dwyer V; Lloyd-McKernan A
    Cont Lens Anterior Eye; 2020 Apr; 43(2):159-168. PubMed ID: 31548151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular demodicosis as a potential cause of pediatric blepharoconjunctivitis.
    Liang L; Safran S; Gao Y; Sheha H; Raju VK; Tseng SC
    Cornea; 2010 Dec; 29(12):1386-91. PubMed ID: 20847679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of treatments for Demodex blepharitis: A systematic review and meta-analysis.
    Navel V; Mulliez A; Benoist d'Azy C; Baker JS; Malecaze J; Chiambaretta F; Dutheil F
    Ocul Surf; 2019 Oct; 17(4):655-669. PubMed ID: 31229586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lotilaner Ophthalmic Solution 0.25% for Demodex Blepharitis: Randomized, Vehicle-Controlled, Multicenter, Phase 3 Trial (Saturn-2).
    Gaddie IB; Donnenfeld ED; Karpecki P; Vollmer P; Berdy GJ; Peterson JD; Simmons B; Edell ARP; Whitson WE; Ciolino JB; Baba SN; Holdbrook M; Trevejo J; Meyer J; Yeu E;
    Ophthalmology; 2023 Oct; 130(10):1015-1023. PubMed ID: 37285925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Efficacy and Safety of Two Tea Tree Oil-Based Formulations in Patients with Chronic Blepharitis: A Double-Blinded Randomized Clinical Trial.
    Ergun SB; Saribas GS; Yarayici S; Elmazoglu Z; Cardak A; Ozogul C; Ilhan MN; Karasu C; Evren Kemer O
    Ocul Immunol Inflamm; 2020 Aug; 28(6):888-897. PubMed ID: 31429629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Demodex and ocular surface disease].
    Ben Hadj Salah W; Baudouin C; Doan S; Angoulvant A; Gottlieb J; Bénichou J; Da Cunha E; Eid L; Labetoulle M; Rousseau A
    J Fr Ophtalmol; 2020 Dec; 43(10):1069-1077. PubMed ID: 33127178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Blepharoexfoliation in Demodex Blepharitis: A Randomized Comparative Study.
    Mohammad-Rabei H; Arabi A; Shahraki T; Rezaee-Alam Z; Baradaran-Rafii A
    Cornea; 2023 Jan; 42(1):44-51. PubMed ID: 35439775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved Demodex diagnosis in the clinical setting using a novel in situ technique.
    Muntz A; Purslow C; Wolffsohn JS; Craig JP
    Cont Lens Anterior Eye; 2020 Aug; 43(4):345-349. PubMed ID: 31806355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [DEMODEX PARASITES AND CHRONIC BLEPHARITIS].
    Lavy I
    Harefuah; 2019 Feb; 158(2):112-114. PubMed ID: 30779489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis of Observational & Experimental Studies.
    Talha M; Haris Ali M; Fatima E; Nadeem A; Ahmed A; Nashwan AJ
    Am J Ophthalmol; 2024 Aug; 264():8-16. PubMed ID: 38513948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and treatment of filamentary keratitis in a patient with Demodex infestation--an overlooked risk factor: a case report.
    Chen J; Yao Q; Chen J; Li Y
    BMC Ophthalmol; 2023 May; 23(1):209. PubMed ID: 37170186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blepharitis: always remember demodex.
    Bhandari V; Reddy JK
    Middle East Afr J Ophthalmol; 2014; 21(4):317-20. PubMed ID: 25371637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demodex treatment in external ocular disease: the outcomes of a Tasmanian case series.
    Nicholls SG; Oakley CL; Tan A; Vote BJ
    Int Ophthalmol; 2016 Oct; 36(5):691-6. PubMed ID: 26843091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Lotilaner Ophthalmic Solution 0.25% for the Treatment of Demodex Blepharitis: A Meta-Analysis of Randomized Controlled Trials.
    Muhammad Muneeb Akhtar S; Fareed A; Sohaib Asghar M; Mumtaz M; Kaur S
    Cont Lens Anterior Eye; 2024 Jun; 47(3):102148. PubMed ID: 38514290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ocular demodicosis: A review.
    Moris García V; Valenzuela Vargas G; Marín Cornuy M; Aguila Torres P
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Jul; 94(7):316-322. PubMed ID: 31151686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular demodicosis.
    Patel KG; Raju VK
    W V Med J; 2013; 109(3):16-8. PubMed ID: 23798275
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment options for demodex blepharitis: patient choice and efficacy.
    Hirsch-Hoffmann S; Kaufmann C; Bänninger PB; Thiel MA
    Klin Monbl Augenheilkd; 2015 Apr; 232(4):384-7. PubMed ID: 25902082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.